ANSELL LIMITED (ANN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ANN - ANSELL LIMITED

FNArena Sector : Commercial Services & Supplies
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 1.87
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Ansell is an Australian manufacturer of protective industrial equipment and household and medical gloves. It is the remnant of Pacific Dunlop, once a mighty conglomerate that listed in 1985. The name was changed to Ansell in 2002.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$23.49

05 Dec
2023

-0.160

OPEN

$23.59

-0.68%

HIGH

$23.72

162,346

LOW

$23.40

TARGET
$25.61 9.0% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
AIM . ASB . CUP . DGL . KPG . QHL . RDX . SRV .
FNARENA'S MARKET CONSENSUS FORECASTS
ANN: 1
Title FY24
Forecast		 FY25
Forecast
EPS (cps) 148.8 xxx
DPS (cps) 63.4 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 16.4 xxx
Dividend Yield 2.6% xxx
Div Pay Ratio(%) 42.6% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 2.03%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.87

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 18/08 - ex-div 39.56c (franking 0%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx174.6
DPS All xxxxxxxxxxxxxxx69.5
Sales/Revenue xxxxxxxxxxxxxxx2,460.6 M
Book Value Per Share xxxxxxxxxxxxxxx1,908.5
Net Operating Cash Flow xxxxxxxxxxxxxxx243.5 M
Net Profit Margin xxxxxxxxxxxxxxx8.96 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx9.49 %
Return on Invested Capital xxxxxxxxxxxxxxx7.48 %
Return on Assets xxxxxxxxxxxxxxx5.92 %
Return on Equity xxxxxxxxxxxxxxx9.49 %
Return on Total Capital xxxxxxxxxxxxxxx9.66 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx50.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx176 M
Long Term Debt xxxxxxxxxxxxxxx566 M
Total Debt xxxxxxxxxxxxxxx743 M
Goodwill - Gross xxxxxxxxxxxxxxx1,481 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx239 M
Price To Book Value xxxxxxxxxxxxxxx1.40

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx99.9 M
Capex % of Sales xxxxxxxxxxxxxxx4.06 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,551 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx613 M
Research & Development xxxxxxxxxxxxxxx27 M
Investments - Total xxxxxxxxxxxxxxx18 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.1

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

15/08/2023

3

Neutral

$24.95

6.22%

Ansell's FY23 health care earnings were below Macquarie's forecasts in FY23 and declined by -18% as the segment was affected by destocking. Industrial EBIT rose 10%, supported by price increases and cost initiatives.

Macquarie expects improved growth from FY25, noting the capacity on the balance sheet for growth initiatives and/or capital management.

Yet in the near term the outlook is uncertain because of customer destocking and macro economic conditions. Neutral retained. Target is reduced to $24.95 from $25.10.

FORECAST
Macquarie forecasts a full year FY24 dividend of 69.42 cents and EPS of 147.60 cents.
Macquarie forecasts a full year FY25 dividend of 78.48 cents and EPS of 173.56 cents.

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >

ANN STOCK CHART

FNArena News on ANN

1
Rudi’s View: Bear&Bull Market To Continue (?) In 2024

Dec 06 2023 - Rudi's View
2
Rudi’s View: Outlook 2024, Is History Our Guide?

Nov 08 2023 - Rudi's View
3
Rudi’s View: A Market Of Contradictions

Nov 01 2023 - Rudi's View
4
ESG Focus: Strong Reporting Season For Circularity, Nature, Biodiversity and AI

Oct 02 2023 - ESG Focus
5
Rudi’s View: Outlook Negative, With Plenty Of Silver Linings

Sep 06 2023 - Rudi's View

Latest Commercial Services & Supplies News

1
ESG Focus: Rounding Up A Psychosocial FY23 Season

Nov 20 2023 - ESG Focus
2
Rise Of The Machines: AI Has Arrived

Nov 16 2023 - Feature Stories
3
Altium: Low In Place

Nov 14 2023 - Technicals
4
In The Bin; ASX-Listed Waste Companies

Nov 02 2023 - Australia
5
Dropsuite Trajectory Impresses

Oct 25 2023 - Small Caps
6
Treasure Chest: Silk Logistics

Sep 28 2023 - Treasure Chest
7
Treasure Chest: ALS Has A Turn-Around Option

Sep 19 2023 - Treasure Chest
8
Lindsay Australia: Transported To Growth

Sep 13 2023 - Small Caps
9
NextDC Invests For Megatrend Megademand

Sep 06 2023 - Australia
10
USA Market Too Small For Overachieving Life360

Aug 17 2023 - Small Caps